Related Experiment Videos
Nortriptyline capacity-limited metabolism: a case report.
Journal of Clinical Psychopharmacology
|December 1, 1984
Summary
This case report details a patient exhibiting dose-dependent nortriptyline pharmacokinetics, with significantly prolonged half-lives and elevated plasma concentrations at higher doses. Despite high levels, toxicity was avoided due to increased protein binding.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Pharmacokinetics
Background:
- Tricyclic antidepressants (TCAs) like nortriptyline are commonly prescribed for various conditions.
- Understanding the pharmacokinetic profile of TCAs is crucial for optimizing patient outcomes and minimizing adverse effects.
- Individual variability in drug metabolism and response necessitates careful monitoring, especially in therapeutic drug monitoring.
Observation:
- A 62-year-old patient displayed unusual dose-dependent kinetics for nortriptyline.
- Plasma concentrations and half-lives of nortriptyline increased significantly with escalating doses (10 mg every other day, 10 mg daily, 25 mg daily).
- Free plasma nortriptyline concentrations also showed a dose-dependent increase, correlating with total plasma levels.
Findings:
- Steady-state total plasma nortriptyline levels were 38, 86, and 647 ng/ml at increasing doses.
- Free plasma nortriptyline concentrations were 0.37, 0.9, and 6.6 ng/ml, respectively.
- Nortriptyline half-lives extended from 30.4 hours to 64 hours with dose escalation.
- The patient did not exhibit toxicity despite high total plasma TCA concentrations, attributed to increased plasma protein binding.
Implications:
- This case highlights potential inter-individual variability in nortriptyline pharmacokinetics, diverging from typical TCA profiles.
- Increased plasma protein binding may serve as a protective mechanism against TCA toxicity in certain patients.
- Further research into the factors influencing nortriptyline protein binding and its clinical significance is warranted.